LRCXLam Research

$230.28+62% 1Y

Is the business good?

Excellent

A genuinely good business: 8 of 9 health tests passed, earnings fully cash-backed (0.9×), and margins widening.

4 good
Fundamental health (F-score)8 / 9SEC EDGAR · Jun 28, 2026

High fundamental quality. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash0.90×derived · Sep 27, 2026

Operating profit is fully backed by cash. Conversion is worsening vs a year ago.

Margin direction, 3 years+8.5 pts

Positive operating leverage, operating profit is growing faster than sales, so margins widen as the business scales.

Where ROE comes from31% ROA

High-quality, exceptional returns on the assets themselves, not leverage. ROE 61% = margin × turnover × leverage.

Unless marked, from derived.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversionbehind 73% of the market
Leverage (Debt/EBITDA)top 7% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is LRCX?

Lam Research earns 75% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.

75%

Return on invested capital · cost of capital 9.0% · 66 points above what the capital costs: growth creates value

Operating margin
37%

Operating margin · Semiconductor Equipment & Materials median 10% · 12 months to Q1 2027

Cash conversion
0.90×

Cash conversion · 1.11× a year ago · operating cash flow covers the operating profit after tax

Share count, year on year
−1.1%

Share count, year on year · bought back, each share owns more of the company

Operating margin by fiscal year
YearOperating margin
FY202131%
FY202231%
FY202330%
FY202429%
FY202532%
FY202635%
Details›
Gross margin12 months to Q1 2027
51%
Operating margin12 months to Q1 2027
37%
Net margin12 months to Q1 2027
32%
Free cash flow margin
25%
R&D as % of revenue
9.4%
Revenue, trailing twelve months
$26.1B
Free cash flow, trailing twelve months
$6.54B
Net income, trailing twelve months
$8.45B
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
75%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.

Customers and suppliers

Who buys from LRCX and who it buys from, as the companies report it.

16%of revenue comes from customer 1, the largest of 4 disclosed customers
Customerswho buys
Supplierswho it buys from

A company has to disclose every customer behind 10% or more of its revenue. Each share comes from the latest annual report of the company that states it and shows on both companies’ pages; LRCX’s own figures are from its FY2026 10-K. Smaller customers and suppliers go unreported. A link without a share is named in one of the two companies’ annual reports, without a figure.